section name header

Y-Site Injection Compatibility (1:1 Mixture)

Cefiderocol sulfate tosylate

(Mfr: SHI)(Conc: 20 mg/mLb)

QMark

Amikacin sulfate

(Mfr: SGT)(Conc: 5 mg/mLb)

Remarks:

Results of subvisual tests indicate high counts of particles =2 and =10 µm when cefiderocol is added to amikacin; not observed when order of mixing was reversed

Ref:

3662